Yarbrough Capital LLC Has $273,000 Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
Yarbrough Capital LLC Has $273,000 Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
Yarbrough Capital LLC decreased its position in Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) by 17.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,492 shares of the company's stock after selling 11,144 shares during the quarter. Yarbrough Capital LLC's holdings in Cellebrite DI were worth $273,000 at the end of the most recent reporting period.
根據Yarbough Capital LLC最近提交給美國證券交易委員會(SEC)的文件,該公司在第二季度將其在Cellebrite DI Ltd.(納斯達克代碼:CLBT-GET評級)的頭寸減少了17.2%。該公司在本季度出售了11,144股後,持有53,492股該公司股票。在最近一次報告期結束時,Yarbough Capital LLC持有的Cellebrite DI價值27.3萬美元。
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. CIBC Asset Management Inc raised its stake in shares of Cellebrite DI by 5.8% in the 1st quarter. CIBC Asset Management Inc now owns 2,352,733 shares of the company's stock valued at $15,057,000 after purchasing an additional 129,244 shares during the period. Phoenix Holdings Ltd. raised its stake in shares of Cellebrite DI by 303.6% in the 1st quarter. Phoenix Holdings Ltd. now owns 2,296,345 shares of the company's stock valued at $14,706,000 after purchasing an additional 1,727,379 shares during the period. Greenhaven Road Investment Management L.P. grew its holdings in shares of Cellebrite DI by 69.7% in the 1st quarter. Greenhaven Road Investment Management L.P. now owns 2,000,000 shares of the company's stock valued at $12,800,000 after acquiring an additional 821,364 shares in the last quarter. Blair William & Co. IL grew its holdings in shares of Cellebrite DI by 3,021.1% in the 1st quarter. Blair William & Co. IL now owns 523,978 shares of the company's stock valued at $3,353,000 after acquiring an additional 507,190 shares in the last quarter. Finally, ARK Investment Management LLC bought a new position in shares of Cellebrite DI in the 1st quarter valued at about $2,621,000. Institutional investors and hedge funds own 20.41% of the company's stock.
其他幾家對衝基金和其他機構投資者最近也調整了對該公司的持股。加拿大帝國商業銀行資產管理公司在第一季度將其在Cellebrite DI的股份增加了5.8%。加拿大帝國商業銀行資產管理公司在此期間額外購買了129,244股後,現在擁有2,352,733股該公司股票,價值15,057,000美元。鳳凰控股有限公司在第一季度增持了Cellebrite DI的股份303.6%。鳳凰衞視控股有限公司目前持有該公司2,296,345股股票,價值14,706,000美元,在此期間又購買了1,727,379股。Greenaven Road Investment Management L.P.在第一季度持有的Cellebrite DI股票增加了69.7%。Greenaven Road Investment Management L.P.在上個季度增持了821,364股後,現在擁有200萬股該公司股票,價值12,800,000美元。Blair William&Co.IL在第一季度增持了3,021.1%的Cellebrite DI股票。在上個季度增持了507,190股之後,Blair William&Co.IL現在持有523,978股該公司股票,價值3,353,000美元。最後,方舟投資管理有限責任公司在第一季度購買了Cellebrite DI的新頭寸,價值約2,621,000美元。機構投資者和對衝基金持有該公司20.41%的股票。
Cellebrite DI Trading Down 2.0 %
Cellebrite DI降價2.0%
Shares of NASDAQ:CLBT traded down $0.09 during trading on Friday, reaching $4.37. 61,893 shares of the stock were exchanged, compared to its average volume of 144,907. Cellebrite DI Ltd. has a 12 month low of $4.10 and a 12 month high of $12.49. The stock has a 50-day moving average price of $5.12 and a 200-day moving average price of $5.43. The firm has a market cap of $823.92 million, a PE ratio of 5.91, a PEG ratio of 10.56 and a beta of 0.87.
納斯達克:中國電信股價週五下跌0.09美元,至4.37美元。該股成交量為61,893股,而平均成交量為144,907股。Cellebrite DI Ltd.的股價跌至4.10美元的12個月低點和12.49美元的12個月高點。該股的50日移動均線價格為5.12美元,200日移動均線價格為5.43美元。該公司市值為8.2392億美元,市盈率為5.91倍,市盈率為10.56倍,貝塔係數為0.87倍。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
Cellebrite DI Company Profile
Cellebrite DI公司簡介
(Get Rating)
(獲取評級)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Cellebrite DI Ltd.為法律批准的調查開發解決方案。其DI平臺允許用户在整個調查生命週期中收集、審查、分析和管理與法律批准的調查有關的數字數據,並在各種案件中使用解決方案,包括剝削兒童、兇殺、反恐、邊境控制、性犯罪、人口販運、企業安全、知識產權盜竊和民事訴訟。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- No One Told These 3 Stocks It's a Down Week
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- 免費獲取StockNews.com關於Cellebrite DI(CLBT)的研究報告
- 股市:紅海中的三座強國
- 第四季度值得考慮的3家銀行
- 沒有人告訴這三隻股票這是下跌的一週
- MarketBeat:回顧一週9/12-9/16
- 有什麼辦法可以治癒Teladoc股票的問題嗎?
Want to see what other hedge funds are holding CLBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating).
想看看還有哪些對衝基金持有CLBT嗎?訪問HoldingsChannel.com獲取Cellebrite DI Ltd.(納斯達克代碼:CLBT-GET Rating)的最新13F備案文件和內幕交易信息。
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
接受《凱爾布賴特DI日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cellebrite DI和相關公司的最新新聞和分析師評級的每日簡要摘要。